Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6093 | 1465 | 40.1 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
39 | 32196 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DIFFUSE LARGE B CELL LYMPHOMA | Author keyword | 93 | 24% | 23% | 341 |
2 | PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA | Author keyword | 47 | 81% | 2% | 29 |
3 | GRAY ZONE LYMPHOMA | Author keyword | 32 | 88% | 1% | 15 |
4 | DOUBLE HIT LYMPHOMA | Author keyword | 27 | 74% | 1% | 20 |
5 | PRIMARY MEDIASTINAL B CELL LYMPHOMA | Author keyword | 25 | 73% | 1% | 19 |
6 | PRIMARY MEDIASTINAL LYMPHOMA | Author keyword | 24 | 91% | 1% | 10 |
7 | DLBCL | Author keyword | 24 | 27% | 5% | 75 |
8 | DOUBLE HIT | Author keyword | 13 | 61% | 1% | 14 |
9 | MEDIASTINAL B CELL LYMPHOMA | Author keyword | 12 | 86% | 0% | 6 |
10 | LYMPHOID CANC | Address | 12 | 29% | 2% | 34 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | R CHOP | 92 | 47% | 10% | 144 |
2 | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | 65 | 67% | 4% | 59 |
3 | GERMINAL CENTER PHENOTYPE | 46 | 75% | 2% | 33 |
4 | DIFFUSE LARGE CELL | 40 | 66% | 3% | 37 |
5 | CHOP CONSORTIUM PROGRAM | 32 | 78% | 1% | 21 |
6 | GRAY ZONE LYMPHOMA | 25 | 77% | 1% | 17 |
7 | BCL 2 ASSOCIATED RESISTANCE | 24 | 91% | 1% | 10 |
8 | MYC REARRANGEMENTS | 19 | 74% | 1% | 14 |
9 | DE NOVO CD5 | 18 | 83% | 1% | 10 |
10 | DLBCL | 15 | 43% | 2% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Diffuse large B-cell lymphoma-treatment approaches in the molecular era | 2014 | 23 | 122 | 46% |
Mechanisms of Disease: Aggressive Lymphomas. | 2010 | 184 | 97 | 28% |
Genetic lesions in diffuse large B-cell lymphomas | 2015 | 1 | 168 | 60% |
The Gray Zone Between Burkitt's Lymphoma and Diffuse Large B-Cell Lymphoma From a Genetics Perspective | 2011 | 48 | 45 | 76% |
Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era | 2014 | 10 | 108 | 53% |
Double-hit B-cell lymphomas | 2011 | 187 | 118 | 23% |
MYC-Associated and Double-Hit Lymphomas: A Review of Pathobiology, Prognosis, and Therapeutic Approaches | 2014 | 8 | 68 | 51% |
Aggressive B-Cell Lymphomas: A Review and Practical Approach for the Practicing Pathologist | 2015 | 1 | 72 | 46% |
Germinal centres and B cell lymphomagenesis | 2015 | 2 | 154 | 26% |
Targeting pathological B cell receptor signalling in lymphoid malignancies | 2013 | 77 | 133 | 14% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LYMPHOID CANC | 12 | 29% | 2.3% | 34 |
2 | BIOINFORMAT MOL ANAL SECT | 4 | 38% | 0.6% | 9 |
3 | HEMATOPATHOL SECT | 4 | 10% | 2.5% | 37 |
4 | CLIN HAEMATOL DIAGNOST | 3 | 57% | 0.3% | 4 |
5 | REFERENCE LYMPH NODE PATHOL HEMATOPATHOL | 3 | 43% | 0.4% | 6 |
6 | LYMPHOID MALIGNANCIES BRANCH | 3 | 27% | 0.7% | 10 |
7 | LYMPH NODE REGISTRY | 2 | 15% | 1.0% | 14 |
8 | LYMPHOID MALIGNANCY BRANCH | 2 | 50% | 0.2% | 3 |
9 | AO ST ANDREA | 2 | 40% | 0.3% | 4 |
10 | HEMATOL ONCOL MOL CELLULAR PHARMACOL | 2 | 33% | 0.3% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000219909 | FOLLICULAR LYMPHOMA//T1418//IN SITU FOLLICULAR LYMPHOMA |
2 | 0.0000175295 | PLASMABLASTIC LYMPHOMA//PLASMABLASTIC//HUMAN IMMUNODEFICIENCY VIRUS NEGATIVE |
3 | 0.0000148849 | FOLLICULAR LYMPHOMA//NON HODGKINS LYMPHOMA//AGGRESSIVE NON HODGKINS LYMPHOMA |
4 | 0.0000146931 | POKEMON//BCL6//HIC1 |
5 | 0.0000134785 | LYMPHOBLASTIC LYMPHOMA//BURKITTS LYMPHOMA//BURKITT LYMPHOMA |
6 | 0.0000099467 | MANTLE CELL LYMPHOMA//T1114//BCL 1 |
7 | 0.0000081143 | RIZ1//PRDM//RIZ |
8 | 0.0000078269 | INTERIM PET//INTERIM PET CT//PET IMAGING ST THOMAS |
9 | 0.0000075269 | HODGKINS DISEASE//NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA//HODGKIN LYMPHOMA |
10 | 0.0000073119 | SPLENIC MARGINAL ZONE LYMPHOMA//NODAL MARGINAL ZONE LYMPHOMA//MONOCYTOID B CELL LYMPHOMA |